Quantitative analysis of influenza A (H3N2) E119V and R292K variants in clinical specimens by real-time reverse transcription polymerase chain reaction.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Clinical Virology

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jcv.2015.05.018PMID 26071346
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influenza Viral Load and Peramivir Kinetics after Single Administration and Proposal of Regimens for Peramivir Administration against Resistant Variants

  2014cited by this paper
• Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients.

  2014cited by this paper
• Sequential Influenza B Viral Load and Susceptibility in Children Treated With Oseltamivir and Zanamivir

  2014cited by this paper
• Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS).

  2013cited by this paper
• Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations.

  2013cited by this paper
• Phase III Randomized, Double-Blind Study Comparing Single-Dose Intravenous Peramivir with Oral Oseltamivir in Patients with Seasonal Influenza Virus Infection

  2011cited by this paper
• Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance.

  2011cited by this paper
• Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.

  2011influential reference
• Efficacy, Safety, and Pharmacokinetics of Intravenous Peramivir in Children with 2009 Pandemic H1N1 Influenza A Virus Infection

  2011cited by this paper
• Intravenous Peramivir for Treatment of Influenza A and B Virus Infection in High-Risk Patients

  2011cited by this paper
• Novel Genotyping and Quantitative Analysis of Neuraminidase Inhibitor Resistance-Associated Mutations in Influenza A Viruses by Single-Nucleotide Polymorphism Analysis

  2011cited by this paper
• Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection

  2010cited by this paper
• Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.

  2010cited by this paper
• Assessing the Viral Fitness of Oseltamivir-Resistant Influenza Viruses in Ferrets, Using a Competitive-Mixtures Model

  2010cited by this paper
• Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.

  2009cited by this paper
• Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996–2007

  2009cited by this paper
• Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses.

  2009cited by this paper
• Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

  2009cited by this paper
• Novel Wide-Range Quantitative Nested Real-Time PCR Assay for Mycobacterium tuberculosis DNA: Clinical Application for Diagnosis of Tuberculous Meningitis

  2008cited by this paper
• Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.

  2007cited by this paper
• Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.

  2006cited by this paper
• Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use

  2006cited by this paper
• HOSPITAL-BASED EPIDEMIOLOGIC SURVEY OF MALIGNANCIES IN CHILDREN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS IN THAILAND

  2005cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

  2004cited by this paper
• Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir

  2003cited by this paper
• Oral oseltamivir treatment of influenza in children

  2001cited by this paper
• Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza

  2000cited by this paper
• Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir.

  2000cited by this paper
• Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial

  2000cited by this paper
• Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

  2000cited by this paper
• Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

  2000cited by this paper
• Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

  1997cited by this paper
• Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections

  1997cited by this paper
• Patterns of shedding of myxoviruses and paramyxoviruses in children.

  1981cited by this paper
• Viral shedding patterns of children with influenza B infection.

  1979cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir : descriptive study

  year unknowninfluential reference

• The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir

  2024cites this paper
• Pharmacologic background and clinical issue of anti-influenza drugs

  2024cites this paper
• Development of Digital Droplet PCR Targeting the Influenza H3N2 Oseltamivir-Resistant E119V Mutation and Its Performance through the Use of Reverse Genetics Mutants

  2023cites this paper
• Population analysis of oseltamivir-resistant variants for the rapid prediction of drug susceptibility by real-time reverse transcription polymerase chain reaction

  2022cites this paper